ATE493121T1 - Perkutane resorbierbare zubereitungen - Google Patents

Perkutane resorbierbare zubereitungen

Info

Publication number
ATE493121T1
ATE493121T1 AT00944383T AT00944383T ATE493121T1 AT E493121 T1 ATE493121 T1 AT E493121T1 AT 00944383 T AT00944383 T AT 00944383T AT 00944383 T AT00944383 T AT 00944383T AT E493121 T1 ATE493121 T1 AT E493121T1
Authority
AT
Austria
Prior art keywords
salt
percutane
absorbable preparations
basic substance
addition salt
Prior art date
Application number
AT00944383T
Other languages
English (en)
Inventor
Yasunori Takada
Koji Tanaka
Yasuhiro Ikeura
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE493121T1 publication Critical patent/ATE493121T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00944383T 1999-07-15 2000-07-11 Perkutane resorbierbare zubereitungen ATE493121T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20134099 1999-07-15
PCT/JP2000/004609 WO2001005381A1 (en) 1999-07-15 2000-07-11 Percutaneously absorbable preparations

Publications (1)

Publication Number Publication Date
ATE493121T1 true ATE493121T1 (de) 2011-01-15

Family

ID=16439413

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00944383T ATE493121T1 (de) 1999-07-15 2000-07-11 Perkutane resorbierbare zubereitungen

Country Status (14)

Country Link
US (1) US7615237B1 (de)
EP (1) EP1197209B1 (de)
JP (1) JP4627945B2 (de)
KR (1) KR100686527B1 (de)
CN (1) CN1361686A (de)
AT (1) ATE493121T1 (de)
AU (1) AU771637B2 (de)
BR (1) BRPI0012401B1 (de)
CA (1) CA2379147C (de)
DE (1) DE60045446D1 (de)
DK (1) DK1197209T3 (de)
ES (1) ES2356704T3 (de)
TW (1) TWI234470B (de)
WO (1) WO2001005381A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4865958B2 (ja) 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
ATE464887T1 (de) * 2001-05-31 2010-05-15 Hisamitsu Pharmaceutical Co Perkutan resorbierbare pflaster
TWI327074B (en) * 2003-05-07 2010-07-11 Hisamitsu Pharmaceutical Co Ultra violet shielding patch
WO2006051818A1 (ja) * 2004-11-10 2006-05-18 Hisamitsu Pharmaceutical Co., Inc. 外用製剤及び貼付剤
JP5315051B2 (ja) * 2005-07-08 2013-10-16 千寿製薬株式会社 オロパタジンを含む眼科用経皮吸収型製剤
CN100420726C (zh) * 2005-09-19 2008-09-24 上海安立霸电器有限公司 医用热熔压敏胶型基质及制备
JP4869697B2 (ja) * 2005-12-08 2012-02-08 日東電工株式会社 外用剤
JP5190358B2 (ja) * 2006-02-28 2013-04-24 久光製薬株式会社 経皮吸収型製剤
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
WO2009048027A1 (ja) * 2007-10-09 2009-04-16 Arkray, Inc. 免疫関連遺伝子の多型の検出用プローブおよびその用途
AU2008327436B2 (en) 2007-11-22 2013-09-05 Medrx Co., Ltd. External preparation composition comprising fatty acid-based ionic liquid as active ingredient
JPWO2010103844A1 (ja) * 2009-03-11 2012-09-13 興和株式会社 鎮痛・抗炎症剤含有外用剤
WO2010103845A1 (ja) * 2009-03-11 2010-09-16 興和株式会社 鎮痛・抗炎症剤含有外用剤
JP6131523B2 (ja) * 2011-03-25 2017-05-24 大正製薬株式会社 ロキソプロフェン含有外用剤
JP5878715B2 (ja) * 2011-09-22 2016-03-08 久光製薬株式会社 貼付剤
US8617579B2 (en) * 2012-04-16 2013-12-31 Conopco, Inc. Pre-blended mixtures of specific naturally sourced liquid materials structured with naturally sourced high melting point structuring material
GB201301774D0 (en) * 2013-01-31 2013-03-20 Henry Richard Composition
EP2926832A1 (de) * 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmazeutische formulierungen von loxoprofen zur topischen anwendung
CN104288167B (zh) * 2014-10-29 2017-08-25 马应龙药业集团股份有限公司 一种治疗痔疮的七叶皂苷钠制剂及其制备方法
JP6304457B2 (ja) * 2015-08-27 2018-04-04 東洋インキＳｃホールディングス株式会社 貼付剤
CN105693556A (zh) * 2016-03-01 2016-06-22 巴斯特医药科技（常州）有限公司 卡巴拉汀酒石酸盐的转化方法及其产物制成的贴片

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164714A (ja) 1983-03-09 1984-09-17 Sekisui Chem Co Ltd 治療用接着テ−プもしくはシ−ト
JPS59164715A (ja) 1983-03-09 1984-09-17 Nitto Electric Ind Co Ltd 外用部材の製法
JPS6112621A (ja) * 1984-06-27 1986-01-21 Lion Corp パツプ剤
JPS61260026A (ja) 1985-05-14 1986-11-18 Showa Denko Kk 経皮吸収性を高めた皮膚外用剤
JPH04217925A (ja) 1990-03-27 1992-08-07 Nippon Saafuakutanto Kogyo Kk 新規な解熱消炎鎮痛剤組成物
JP2849937B2 (ja) 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
JPH06112621A (ja) * 1992-09-29 1994-04-22 Fujitsu Ltd モジュールのスタンドオフ構造
JP2569396B2 (ja) 1992-12-04 1997-01-08 株式会社太平洋 経皮投与型薬物用貼付剤
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5795916A (en) * 1994-08-09 1998-08-18 Tsumura & Co. Composition of external preparation
US5968533A (en) * 1994-11-15 1999-10-19 Porter; Steven S. Skin care compositions and methods
JP3908795B2 (ja) 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
KR100277803B1 (ko) 1995-03-10 2001-01-15 가나이 쓰도무 3차원 그래픽 표시장치
ATE205240T1 (de) * 1995-07-04 2001-09-15 Kowa Co Hydrophiles klebemittel
EP0788791A4 (de) * 1995-09-07 1998-04-22 Otsuka Pharma Co Ltd Mit niedrigem pressdrucktablettierte brausezubereitung
CN1210463A (zh) * 1996-02-07 1999-03-10 株式会社津村 透明双氯芬酸钠的水溶液以及它的药物组合物
JPH09316007A (ja) 1996-05-31 1997-12-09 Advanced Sukin Res Kenkyusho:Kk 局所適用組成物
JP3725613B2 (ja) 1996-06-13 2005-12-14 積水化学工業株式会社 外用貼付剤
JP3672205B2 (ja) 1996-10-08 2005-07-20 東光薬品工業株式会社 皮膚低刺激性経皮吸収貼付剤
JP4275751B2 (ja) 1996-12-27 2009-06-10 久光製薬株式会社 外用組成物
JPH10316560A (ja) 1997-05-21 1998-12-02 Toko Yakuhin Kogyo Kk 貼付剤
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
KR19990026792A (ko) 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제

Also Published As

Publication number Publication date
EP1197209A1 (de) 2002-04-17
AU5852100A (en) 2001-02-05
AU771637B2 (en) 2004-04-01
DK1197209T3 (da) 2011-04-04
EP1197209A4 (de) 2005-01-05
KR20020015342A (ko) 2002-02-27
ES2356704T3 (es) 2011-04-12
US7615237B1 (en) 2009-11-10
DE60045446D1 (de) 2011-02-10
CA2379147A1 (en) 2001-01-25
EP1197209B1 (de) 2010-12-29
CA2379147C (en) 2009-09-01
CN1361686A (zh) 2002-07-31
KR100686527B1 (ko) 2007-02-27
BRPI0012401B1 (pt) 2016-09-27
TWI234470B (en) 2005-06-21
JP4627945B2 (ja) 2011-02-09
BR0012401A (pt) 2002-05-21
WO2001005381A1 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
DK1197209T3 (da) Perkutant absorberbare præparater
ATE485815T1 (de) Zubereitungen zur perkutanen absorption
BRPI0307117B8 (pt) amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos
PT1295600E (pt) Medicamento com base em gestagenios que contem acido ascorbico e/ou sais do mesmo para uma aplicacao dermica
AU2575695A (en) Matrix type patch formulation
CA2260185A1 (en) Hormone replacement therapy drug formulations for topical application to the skin
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
ATE182786T1 (de) Pharmazeutische und/oder kosmetische zubereitung
EP1391200A4 (de) Arzneimittel
IT8947701A0 (it) Derivato di piperazina o suo sale, procedimento per produrlo e composizione farmaceutica che lo contiene come ingrediente attivo
NO934706D0 (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
PT1069892E (pt) Sistema terapeutico activavel pela humidade
DE69007592D1 (de) Transdermal absorbierbare Dopaminderivate enthaltende Arzneizubereitungen.
FI961282L (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
BR0312814A (pt) Levamisol / avermectinas ou similares em solvente de pirrolidona
EP0974363A4 (de) Heilmittel für die drogenabhängigkeit
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
FI950165A7 (fi) Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena o n 17-beta-estradioli (vedetön)
EP1426360A4 (de) 2-phenyl-3-heteroaryl propionsäure derivate und deren salze, und diese enthaltende arzneimittel
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
ATE497764T1 (de) Perkutane absorptionszubereitungen mit 3-methyl-1-phenyl-2-pyrazolin-5-on
NO985023D0 (no) Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
CY1106819T1 (el) Φαρμακα για το ξηρο δερμα
BR0208858A (pt) Composição de matéria sólida efervescente, uso da mesma, método para tratamento de um mamìfero que sofre de uma ferida dermal, para tratamento de cicatrização de feridas de um animal lactante que sofre de mastite e para tratamento profilático de um animal lactante propenso a desenvolver mastite
WO2003013613A1 (fr) Preparation medicinale a absorption percutanee

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1197209

Country of ref document: EP